# Eoflow invests 10.85B won in Gonjiam plant for automated insulin patch production line

Eoflow announced a 10.85 billion won investment in its Gonjiam production facility to build an automated production line for its Eopatch wearable insulin pump, including 3.75 billion won for plant expansion and 7.1 billion won for automation equipment. Completion is expected by December 2022.

- Type: Investment
- Announced: 2022-06-03
- Where: Gonjiam, South Korea
- Value: $8.50M (10.8B KRW)
- Starts operating: Dec 2022
- Status: announced
- Capacity: 4 million units per year
- Products: wearable insulin pump (Eopatch)
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [EOFlow](https://endata.com/companies/55385.md)

## Sources

- [medicaltimes.com](https://www.medicaltimes.com/Main/News/NewsView.html/NewsView.html?ID=1147718), 2022-06-03: "이오플로우는 곤지암 생산 시설에 대규모 투자를 진행한다고 3일 밝혔다."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.